Somewhat Positive News Coverage Somewhat Unlikely to Impact Castlight Health, inc. (CSLT) Share Price

Media stories about Castlight Health, inc. (NYSE:CSLT) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Castlight Health, inc. earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave headlines about the software maker an impact score of 45.519733284173 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the headlines that may have impacted Accern Sentiment’s scoring:

Shares of Castlight Health, inc. (NYSE CSLT) traded down $0.05 on Friday, reaching $3.75. The company’s stock had a trading volume of 387,597 shares, compared to its average volume of 332,318. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.94 and a quick ratio of 1.94. Castlight Health, inc. has a 52 week low of $3.05 and a 52 week high of $5.50.

Castlight Health, inc. (NYSE:CSLT) last issued its quarterly earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. The company had revenue of $34.60 million during the quarter, compared to the consensus estimate of $34.61 million. Castlight Health, inc. had a negative return on equity of 32.57% and a negative net margin of 45.14%. Castlight Health, inc.’s revenue was up 35.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.05) EPS. analysts forecast that Castlight Health, inc. will post -0.44 EPS for the current year.

CSLT has been the topic of a number of recent research reports. BidaskClub lowered Castlight Health, inc. from a “sell” rating to a “strong sell” rating in a research note on Thursday, November 9th. Zacks Investment Research raised Castlight Health, inc. from a “hold” rating to a “buy” rating and set a $4.50 target price on the stock in a research note on Monday, October 30th. Canaccord Genuity reaffirmed a “buy” rating and issued a $7.00 target price on shares of Castlight Health, inc. in a research note on Thursday, October 26th. Chardan Capital reduced their target price on Castlight Health, inc. from $6.50 to $6.30 and set a “buy” rating on the stock in a research note on Thursday, October 26th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $5.00 target price on shares of Castlight Health, inc. in a research note on Wednesday, October 25th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. Castlight Health, inc. presently has a consensus rating of “Hold” and an average price target of $5.22.

TRADEMARK VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Castlight Health, inc. (CSLT) Share Price” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://transcriptdaily.com/2017/11/19/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-castlight-health-inc-cslt-share-price.html.

In other news, CEO John C. Doyle sold 13,686 shares of the company’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the sale, the chief executive officer now directly owns 123,705 shares in the company, valued at approximately $458,945.55. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, President Robert Derek Newell acquired 30,000 shares of the company’s stock in a transaction dated Friday, October 27th. The shares were purchased at an average price of $3.95 per share, with a total value of $118,500.00. Following the completion of the acquisition, the president now owns 128,671 shares in the company, valued at $508,250.45. The disclosure for this purchase can be found here. Insiders own 37.43% of the company’s stock.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply